Cigna Combats Colorectal Cancer With Campaign Aimed at Two Million Individuals Due for Screening
More than one million people in the U.S. are survivors of colorectal
cancer, thanks to better prevention, early detection
and treatment improvements, according to the American Cancer
Society. Nevertheless, colorectal cancer remains the third leading cause
of cancer-related deaths in the U.S., and is expected to kill 50,830
Americans in 2013.1
Cigna (NYSE:CI) has been working for the past eight years to turn the
tide against colorectal cancer with its award-winning Colorectal
Cancer Screening Program. The battle continues this year as the
company rolls out an enhanced program in March that will reach two
million people who are due for screening, through a combination of
targeted online messages and direct mail. Cigna
podcast on importance of colorectal cancer screening.
Approximately 300,000 newly eligible individuals covered by a Cigna
medical plan who are 50 to 64 years of age, and whose claims data
indicate they have not had a colorectal cancer screening, will receive
information in the mail about appropriate colon cancer screening
tests, including colonoscopy. In addition, they will be offered
the opportunity to request the InSure® FIT™ screening kit, an easy and
convenient at-home test that is sensitive at detecting abnormalities in
the lower gastrointestinal tract. Cigna has made an arrangement with
Quest Diagnostics (NYSE: DGX) to provide the test kit at no charge, and
the laboratory processing fees are covered as a preventive benefit under
most Cigna plans. Visit www.insuretest.com
for more information about the test.
Eleven thousand Cigna customers who, based on Cigna claims data,
completed either the at-home kit or a fecal occult blood test (FOBT) in
the last three years and did not have a follow-up colonoscopy or
sigmoidoscopy, have been selected to receive an InSure® FIT™ kit this
year.
In addition, all Cigna customers who are age 50 to 64 will see a
targeted message about colon cancer screening and the InSure® FIT™ kit
whenever they logon to the company’s customer web portal, myCigna.com,
between the last week of March and May 30. That means customers using
the web portal for common online activities such as finding a doctor,
refilling a prescription, taking a health assessment, checking on
coverage or reviewing a claim will be exposed to this potentially
life-saving message.
“Colorectal cancer is treatable and preventable, especially if it’s
detected early, which is why educating customers about screening is so
important,” said Scott Josephs, M.D., Cigna national medical officer.
“While colonoscopy is the gold standard for colorectal cancer screening,
many people may prefer the InSure® FIT™ screening test. It’s easy to
complete, and it’s convenient because it can be taken at home. We urge
all of our customers to discuss colorectal cancer screening with their
physician to identify the most appropriate option. We’re pleased to see
screening rates going up in response to our outreach program, and we
hope they’ll go up even more this year due to the enhanced outreach.
More people getting screened means more lives that potentially can be
saved.”
Last March, Cigna's national colorectal cancer screening program reached
nearly 542,000 customers. After six months, Cigna reviewed claims data,
which showed that nearly 31,000 of the targeted individuals had a
screening. That’s a screening rate of 5.7 percent, compared to 4.4
percent in 2010, which is statistically significant. (2011 rates were
not used as a comparison due to different selection criteria.)
Cigna's claims data shows that colonoscopies had the higher screening
rate, at 57 percent of all screenings last year, while the InSure® FIT™
and the FOBT accounted for 43 percent of all screenings. Fifty percent
of the colonoscopies had normal findings, while 48.8 percent detected
polyps that were removed, and 1.2 percent resulted in a diagnosis of
colon cancer. Detecting and removing polyps is important because polyps
can become cancerous.
Since Cigna launched the Colorectal Cancer Screening Program, the
company has partnered with clients to encourage their employees to get
screened for colon cancer. For example, in 2012 Cigna worked with
supermarket operator Harris Teeter to develop a co-branded, targeted
campaign that included e-cards and a newsletter article. As a result of
the campaign, Harris Teeter employees and beneficiaries had a screening
rate of 20.6 percent, nearly four times the Cigna national average.
"Increasing completion rates for cancer screenings was one of our health
promotion goals for 2012,” said Terri Priore, vice president of Benefits
and Administration for Harris Teeter. “These outstanding results show
that working collaboratively with Cigna to develop health improvement
messages and targeting them appropriately can affect an individual’s
decision to get a potentially life-saving screening.”
Cigna customers who receive program information by mail also receive
guidance about what to do if they have specific colorectal cancer
symptoms, such as a change in bowel habits, rectal bleeding or abdominal
pain, which could require a complete evaluation by a physician.
Confidential InSure® FIT™ results are mailed to individuals, who are
encouraged to share positive or negative results with their primary care
physician so that an appropriate follow-up screening plan may be
developed.
About Cigna
Cigna Corporation (NYSE: CI) is a global health service company
dedicated to helping people improve their health, well-being and sense
of security. All products and services are provided exclusively by or
through operating subsidiaries of Cigna Corporation, including
Connecticut General Life Insurance Company, Cigna Health and Life
Insurance Company, Life Insurance Company of North America and Cigna
Life Insurance Company of New York. Such products and services include
an integrated suite of health services, such as medical, dental,
behavioral health, pharmacy, vision, supplemental benefits, and other
related products including group life, accident and disability
insurance. Cigna maintains sales capability in 30 countries and
jurisdictions, and has approximately 78 million customer relationships
throughout the world. To learn more about Cigna®, including links to
follow us on Facebook or Twitter, visit www.cigna.com.
1 American Cancer Society website, Key Statistics About
Colorectal Cancer.